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Increased expression of Na/H4 exchanger in the injured renal tissues
of focal glomeruloscierosis in rats. The renal mRNA expression of
Na/H exchanger (NHE) and the effects of NHE inhibitor, amiloride, on
renal injury were investigated in adriamycin (ADR)-induced glomerulo-
sclerosis model in rats, which progressively developed extensive glomeru-
losclerosis and interstitial fibrosis. NHE-1 mRNA from the cortex of the
ADR rats progressively increased at weeks 4 and 8 and then peaked at
week 16, which paralleled with the degree of glomerular sclerosis and
interstitial fibrosis. The interstitial fibrosis in the ADR-rats was prevented
by a daily administration of amiloride. A simultaneous analysis of the
effects of a high salt diet on NHE-1 mRNA expression or renal injury was
performed in the ADR rats at weeks 2 and 8. Renal or glomerular
hypertrophy was observed in the control or ADR rats fed an 8% NaCl diet
at week 2 and 8 compared to a 1% NaCl diet, while the NHE-1 mRNA
expression was not up-regulated by an 8% NaCl diet at week 2. At week
8, the NHE-1 mRNA expression or glomerulosclerosis and interstitial
fibrosis were enhanced in the ADR rats fed an 8% NaCI diet compared to
a 1% NaCI diet. This histological aggravation by an 8% NaCI diet was
prevented by a daily administration of amiloride but not by furosemide. In
conclusion, the increased NHE-1 mRNA expression and the preventive
effects of amiloride on the renal lesions suggest a potential importance of
NHE in the progressive process of ADR-nephropathy. The high salt diet
had a hypertrophic and destructive effect on kidney or glomeruli in the
ADR rats. The hypertrophic effect of a high salt diet did not seem to be
mediated through NHE activation.
A variety of growth factors has been reported to contribute to
either cellular proliferation or hypertrophy in renal diseases [1—6].
However, the signaling responses of proliferative or hypertrophic
stimuli by growth factors are not well understood. Several studies
have demonstrated that both the Na influx and a rise in
intracellular pH associated with the increased Na/H1 exchanger
(NHE) activity, can stimulate cell mitogenesis and that an early
event of cellular hypertrophy is the enhancement of NHE activity
[7—9]. The stimulation of NHE activity by mitogens or growth
factors leads to an increase in the transmembrane Na influx and
H extrusion with subsequent cytoplasmic alkalization. These
findings suggest that NHE may be involved in either the prolifer-
ative or sclerotic changes of renal diseases [10, 11].
Salt intake has been reported to influence the compensatoly
renal growth in rats [11—16]. Dietary salt restriction also inhibited
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the hypertrophic response to the ablation of renal mass and
markedly reduced glomerular injury in uninephrectomized spon-
taneously hypertensive rats [14, 16]. In these reports, salt restric-
tion did not have any effects on glomerular hemodynamics, while
revealing an independent contribution of compensatory growth to
glomerular injury. Renal growth has been suggested to be related
to NHE activity which is up-regulated by a high salt diet in DahI
salt sensitive rats [13]. Since hypertrophy of the glomerulus is a
phenomenon invariably associated with glomerulosclerosis, the
destructive effects of a high salt diet on renal tissue may thus be
related to the up-regulated NHE activity.
To clarify the contribution of NHE to renal injury and the role
of NHE for either renal or glomerular hypertrophy induced by a
high salt diet, the NHE-1 mRNA expression and the therapeutic
effects of NHE inhibitor (amiloride) were examined in an adria-
mycin (ADR)-induced progressive renal disease model fed a high
salt diet.
Method
Experimental design
Experiment I. Male Sprague-Dawley (SD) rats, weighing 220 to
250 g were used in the present study. Experimental focal glomer-
ulosclerosis was induced by the intravenous injection of ADR,
0.25 mg/tOO g body weight, dissolved in 0.9% saline, twice at
20-day intervals in SD rats [17]. Control rats were given an
intravenous injection of the same volume of 0.9% saline at the
same interval. The rats were divided into the following three
groups: (1) the control group (control, N = 24), (2) the ADR
group (ADR, N = 18), (3) the aniiloride-treated ADR group
(ADR-Am, N = 6). The rats were fed powdered chow containing
1% NaC1 and 22% protein. All groups were pair-fed to the group
with the minimal ingestion in order to maintain the same caloric
and protein intake. The same amount of food intake was con-
firmed in all groups, and was 22 glday for the first four weeks, 20
g/day for the second four weeks and 17 g/day for the last eight
weeks. Amiloride (1 mg/day) was mixed with powdered chow
according to the amount of food intake. Four to 6 mg of amiloride
was mixed with 100 g of powdered chow, according to diet
ingestion. The control rats and ADR rats were sacrificed on the
day before saline or ADR injection and at weeks 4, 8 or 16 after
the second ADR-injection for the examination of renal histology
and NHE mRNA expression. The ADR-Am rats were histologi-
cally examined only at week 16 and then were compared to either
the control or the ADR rats to examine the effects of amiloride.
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Experiment II. The effects of salt intake on renal destruction and
NHE-1 mRNA expression were investigated in the ADR rats. The
control rats and ADR rats were induced by the same methods as
in the experiment I. The rats were divided into the following six
groups: (1) the control rats fed a 1% NaC1 diet (control-1%, N =
6), (2) the control rats fed an 8% NaC1 diet (Control 8%, N = 6),
(3) the ADR rats fed a 1% NaC1 diet (ADR-1%, N = 8), (4) the
ADR rats fed an 8% NaCl diet (ADR-8%, N = 8), (5) the ADR
rats fed an 8% NaC1 diet and treated with furosemide (ADR-
8%Fu, N 8), (6) the ADR rats fed an 8% NaC1 diet and treated
with amiloride (ADR-8%Am, N = 8). All the groups were
pair-fed to maintain the same caloric and protein intake. The
same amount of food intake was confirmed in all the groups, and
was 17 g!day for the first four weeks and 13 g/day for the second
four weeks. Both the amiloride (1 mg/day) and furosemide (4
mg/day) were mixed with powdered chow according to the amount
of food intake. Six to 8 mg of amiloride or 24 to 32 mg of
furosemide was mixed with 100 g of powdered chow, according to
diet ingestion. Urinary protein, blood pressure, creatinine clear-
ance, renal histology and NHE-1 mRNA expression were exam-
ined at weeks 2 or 8 after the second injection of ADR.
Analytical method
The systolic blood pressure was measured in the conscious rats
by the tail cuff method. The animals were warmed for 10 minutes
at 37°C before the measurement. Urinary protein was examined
by the sulfosalicylic acid method. Serum creatinine was measured
by kinetic creatinine assay.
Histological examination
The kidneys were fixed in neutral buffered formalin and em-
bedded in paraffin for the light microscopic study and sections of
2 m thickness were stained with periodic acid-Schiff. To semi-
quantitate the glomerular matrix, 50 glomeruli were selected at
random, and the degree of glomerular matrix expansion was
determined using a published method [18]. The percentage of
each glomerulus occupied by a mesangial matrix was estimated
and assigned a score beginning with 0 = 0%, 1 + = 1—25%, 2+
26—50%, 3+ = 51—75% and 4+ = 76—100%. The number of
glomeruli showing a lesion of 0 was set nO, 1 + ni, 2+ n2, 3+ n3,
4+ n4, respectively. Fifty glomeruli were examined independently,
and then the sclerosis index was obtained by the following
formula: [OXnO+ lXnl+ 2Xn2+ 3Xn3+ 4Xn4)/50]X 100. To
estimate the relative interstitial volume of the kidney, tissue
sections were examined with a 121-point (100 square) eyepiece
micrometer. Representative sections from the entire cortex were
analyzed by means of a point-counting technique to obtain the
relative interstitial volume. A minimum of five sections (605
points) were randomly selected and counted in all cases. The
diameter of 50 glomeruli which were randomly selected from each
specimen was measured with a micrometer and averaged. A
histological evaluation was made independently by two investiga-
tors without prior knowledge of the experimental groups. The
scores were then averaged between two investigators for each
specimen.
RNA extraction and Northern blot analysis
The total RNA was isolated from the renal cortex, liver and
heart using guanidine isothiocyanate, according to the method of
Chirgwin et al [19]. Ten micrograms of poly (A)+ RNA from the
cortex were subjected to electrophoresis in a 2.2 M formalde-
hyde-1% agarose gel, transferred to the Hybond-N nylon mem-
branes (Amersham Corp., Arlington Heights, Illinois, USA), and
then were fixed by baking at 80°C for two hours.
The cDNA probes used were for rat NHE-1 (provided by Dr.
J Orlowski, Department of Physiology, McGill University, Mon-
treal, Canada) [20], and chicken glyceraldehyde-3-phosphate de-
hydrogenase (GAPDH), which was used as an internal control
probe. The membranes were prehybridized at least for two hours
at 37°C in a hybridization solution (5x SSC, 5x Denhardt's
solution, 0.1 mg/ml of salmon sperm DNA, 0.1% SDS, and 50%
formamide). The cDNA probes were labeled with 32P-dCTP by
the random primer method and hybridized in the hybridization
solution at 42°C overnight. The membranes were washed twice in
2x SSC, 0.1% SDS, and twice in lx SSC, 0.1% SDS at 42°C for
15 minutes. Autoradiography was performed by the standard
methods. The autoradiographies were scanned with a Dual-
wavelength flying-spot CS-9000 scanner (Shimidzu, Tokyo, Japan)
in order to compare and quantitate the relative intensities of the
mRNA bands. The relative intensities were expressed with the
ratio of NHE mRNA / GAPDH mRNA and then compared to
that of the control rats.
Statistical method
The parametric data from multiple groups were compared with an
analysis of variance followed by the t-test with modification by
Bonferroni's method. Significance was defined as P < 0.05.
Results
Experiment I
Experimental focal glomeruloscierosis. As described previously
[18], this model of FGS showed massive proteinuria immediately
after ADR injection, which continued until week 16 (data not
shown). In the ADR rats at week 4, a light microscopic examina-
tion revealed that the glomeruli and interstitium were both fairly
intact. At week 8, focal glomerulosclerosis was scatteringly ob-
served. Tubulointerstitium showed patchy changes with flattened
epithelial cells, round cell infiltration and fibrosis. At week 16,
extensive glonierular sclerosis and hyalinosis, tubular atrophy and
interstitial fibrosis with round cell infiltration were observed.
Figure 1 shows a progressive increase in the degree of glomerular
sclerosis and interstitial fibrosis in this model. The sections from
the control rats showed that the glomeruli and interstitium were
also kept mostly intact throughout the study.
NHE-1 mRNA expression in the ADR rats. A Northern blotting
analysis of the cortical NHE-1 mRNA for the control rats showed
a weak band as a 4.9 kb species. In the ADR rats, cortical NHE
mRNA increased progressively and reached a maximum at week
16, and its pattern was similar to the degree of glomeruloscierosis
or interstitial fibrosis. The amount of RNA applied to the gel was
controlled by assaying for the RNA of GAPDH. This RNA also
remained constant during the disease process. The same results
were obtained in three different experiments. Representative
results are shown in Figure 2. The NHE mRNA expression from
the renal cortex, heart and liver from the control rats and ADR
rats at week 16, was shown in Figure 3. The increased expression
of NHE mRNA was observed only in the cortex and medulla of
the ADR rats at week 16, compared to the control rat, but there
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was no difference in NHE mRNA of the heart or liver between the
ADR and control rats.
Effects of NHE inhibitor on renal histology in the ADR rats. To
examine the effects of NHE inhibitor in the ADR rats, the renal
lesions were compared between the ADR rats and the amiloride-
treated ADR rats (ADR-Am) at week 16. There was no signifi-
cant difference in urinary protein between the ADR and
ADR-Am rats at week 16 (376 94 mg/day and 332 81 mg/day,
respectively). The degree of glomeruloscierosis tended to de-
crease in the ADR-Am rats compared to the ADR rats, but it was
not significant (Fig. 4). In contrast, the degree of interstitial
changes decreased in the ADR-Am rats compared to the ADR
rats.
Fig. 2. Northern blotting of NHE-1 mRNA from kidney cortex. Ten micro-
grams of poly (A)RNA from the cortex of the normal untreated rats (N;
rats sacrificed at the day before the first injection) or the control rats (C)
and the ADR rats (A) at week 4, 8 and 16 weeks after the second injection
was loaded to each lane. Poly (A)4RNA was hybridized with rat NHE-1
cDNA. The blots were rehybridized with GAPDH cDNA to confirm that
approximately equal amounts of RNA were loaded in each lane. The
arrows indicate the sizes of the major transcripts for NHE (4.9 kb) and
GAPDH (1.3 kb).
Experiment II
Laboratoty findings. The body weight, kidney weight, urinary
protein, blood pressure, creatinine clearance (Ccr) and serum
sodium concentration at weeks 2 or 8 are all summarized in Table
1. There were no differences in the body weight among any of the
groups at weeks 2 or 8. The kidney weight significantly increased
in control fed an 8% NaC1 diet (control-8%) and all the ADR rat
groups (ADR-1%, ADR-8%, ADR-8%Fu, ADR-8%Am) com-
pared to the control-1% group. The increases of kidney weight in
the ADR-8% or ADR-8%Fu groups were higher than those of
the ADR-1% or ADR-8%Am groups at week 2. At week 8, no
significant difference in kidney weight were observed among the
ADR rat groups. Massive urinary protein was excreted in all the
ADR rat groups at weeks 2 or 8. However, there were no
significant differences in urinary protein among all the ADR rat
groups. The blood pressure increased slightly but significantly in
all the ADR rat groups compared to either the control-1% or
control 8% group, but no differences were revealed among the
ADR rat groups regardless of the high salt intake. The creatinine
clearance (Ccr) was kept within a normal range in all the groups at
week 2, while it decreased in the ADR-8% or ADR-8%Fu groups
compared to the other groups at week 8. The serum sodium
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Fig. 1. The degree of glomeruloscierosis (A) and interstitial changes (B) in
ADR rats. Symbols are: (LI) control; (rA) ADR rats. The values are
semiquantitative from six rats at each point and expressed as the mean
SEM. * P < 0.01 compared to the control rats.
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Fig. 3. Northern blotting of NHE-1 mRJ'JA from
kidney corteZ medulla, liver and heart. Ten
micrograms of poly (A) RNA from cortex,
medulla, liver and heart of the control rats (C)
and the ADR rats (A) at week 16 after the
second ADR injection was loaded to each lane.
Poly (A) RNA was hybridized with rat NHE-1
cDNA. The arrows indicate the sizes of the
major transcripts for NHE (4.9 kb) and
GAPDH (1.3 kb).
concentration was higher in the control and ADR-8% groups than
in the other groups at weeks 2 or 8.
Histological examination. To evaluate glomerular hypertrophy
in each group, the glomerular diameters were compared among
the groups (Fig. 5). The glomerular diameter increased in the high
salt diet groups (control-8%, ADR-8%, ADR-8%Fu) compared
to control-1% at weeks 2 (Fig. 5A). At week 8, the glomerular
diameters in the control-8% and ADR rats groups (ADR-i%,
ADR-8%, ADR-8%Fu, ADR-8%Am) were larger than that in
the ADR-1% group (Fig. 5B). Further the diameters in the
ADR-8% and ADR-8%Fu groups were significantly enlarged
compared to the control-8% or ADR-1% groups.
To investigate the influence of a high salt diet on renal lesions
and the preventive effects of furosemide or amiloride, the degree
of glomerular sclerosis and interstitial changes were compared
among all the groups (Figs. 6 or 7). No significant glomerular or
tubular changes were observed in any of the groups at week 2 and
in the control-1% and control-8% groups at week 8. Both
glomerulosclerosis and tubulointerstitial changes developed in the
ADR-rat groups at week 8. These lesions were more marked in
the ADR-8% and ADR-8%Fu groups than in the control,
ADR-1% and ADR-8%Am groups at week 8, indicating that the
renal lesions exacerbated by a high salt diet were able to be
reduced in the ADR rats given a daily administration of amiloride
but not with furosemide.
Effect of high salt diet on NHE-1 mRNA. To examine the effects
of a high salt diet on the NHE-1 mRNA expression, the amount
of NHE-1 mRNA was analyzed by the method of Northern
blotting in each group (Fig. 8). At week 2, the renal NHE-1
mRNA was not up-regulated in the high salt diet groups except
for the amiloride-treated rats (ADR-8%Am). At week 8, in-
creased levels of NHE-1 mRNA were found in high salt diet
groups (ADR-8%, ADR-8%Fu, ADR-8%Am). In addition, the
expression of GAPDH mRNA showed no differences among the
groups. After scanning of the RNA transfer blots, the ratio of
NHE-1 mRNA/GAPDH mRNA from three rats in each group
was averaged and compared to the control-i% group. The NHE-1
expression in the ADR-8%, ADR-8%Fu or ADR-8%Am groups
was significantly higher than that in either the control-i%, con-
trol-8% or ADR-1% groups at week 8 (Fig. 9).
Discussion
NHE mRNA expression was up-regulated in the kidney of the
ADR rats in time in parallel with the degree of glomeruloscierosis
or interstitial fibrosis. Further, amiloride, a NHE inhibitor, exerts
mild but significant ameliorative effects on interstitial fibrosis in
the ADR rats. These findings suggested that NHE may contribute
to the progressive renal deterioration in this model. ADR-induced
nephropathy is a model of focal glomeruloscierosis, in which the
initial lesion is an epithelial injury followed by extensive glomer-
ular sclerosis and interstitial fibrosis at the late stage [16]. The
mechanism by which the initial lesion progresses to the marked
renal destruction is still unknown. Recently, a variety of growth
factors has been reported to contribute to the renal histological
changes by either stimulating glomerular cell proliferation or
augmenting extracellular matrix expansion [1—6]. The advanced
renal lesions of ADR rats are glomerulosclerosis and interstitial
fibrosis including fibroblast proliferation, infiltrating cells and
matrix expansion. In our previous study, TGF-j3 was shown to play
an important role in the renal lesions in ADR nephropathy [21].
In addition, the increased mRNA expression of platelet-derived
growth factor (PDGF), hepatocyte growth factor, or insulin-like
growth factor-i was also observed in a kidney tissue specimen of
this model (unpublished data).
Some of the growth factors such as PDGF, fibroblast growth
factor (FGF) or epidermal growth factor (EGF) are known to
stimulate NHE activity and NHE-1 mRNA expression. Increased
Na influx and a rise in intracellular pH are important signals to
cell proliferation induced by EGF [22], a-thrombin or insulin [23].
PDGF and FGF also stimulate the expression of NHE-l mRNA
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Fig. 4. Effects of amiloride on glomeruloscierosis (A) and interstitial changes
(B) in the control rats, the ADR rats (ADR) and the amiloride-treated rats
(ADR-Am). The values are semiquantitative from 6 rats in each group and
are expressed as the mean SEM. *P < 0.01 compared to the control and
ADR-Am groups.
in vascular smooth muscle cells [24]. The increased secretion of
the growth factors may lead to the fibroblast proliferation or
matrix accumulation in the interstitium of the ADR-nephropathy
through the activation of NHE. The histological improvement of
this nephropathy by daily administration of NHE inhibitor may
support the contribution of NHE to the renal lesions. This NHE
activation may be a common process for signaling the responses of
the growth factors involved in renal pathological changes.
NHE is a glycoprotein present in the plasma membrane of
mammalian cells that mediates the neutral exchange of Na and
Ht This transport activity is important for the functioning of a
variety of cellular homeostatic process. The exchanger plays a
central role in the regulation of intracellular pH, participates in
the control of cell volume and the transepithelial absorption, and
secretion of electrolytes. In addition, the exchanger appears to
facilitate the initiation of cellular growth and proliferation in
responses to numerous growth factors and other mitogens [22—
24].
Different forms of NHE exist in several types of tissue, includ-
ing the ileum [25], colon [26], kidney [27, 28] and heart [29]. These
isoforms exhibit differences with respect to plasma membrane
targeting [27, 28], sensitivity to inhibition by amiloride [27, 28}, ion
specificity activation by proton [26, 30]. Recently, the primary
structure of growth factor activated NHE was determined by
molecular cloning and sequencing. This exchanger (NHE-1) is a
94 to 110 kDa glycoprotein which is phosphoylated following
growth factor stimulation in a pattern that parallels the rise in
intracellular pH [30]. In addition, recent reports have also de-
scribed the isolation of cDNAs for three isoforms of the NHE
(NHE-2, NHE-3, NHE-4) from the rabbit [31] and rat [20]. These
isoforms are closely related to NHE-1. NHE-1 mRNA is present
at varying levels in all tissues, whereas NHE-2, NHE-3 and
NHE-4 mRNA exhibit a more limited distribution. The NHE-1
isoform is the most sensitive to inhibition by amiloride, while
other exchanger isoforms have been characterized by their low
affinity for amiloride. In the present study, the enhancement of
renal NHE-1 mRNA expression in ADR nephropathy seems to
explain the significant effect of amiloride on the renal lesions.
A high salt diet aggravated the renal lesions in ADR rats,
resulting in advanced renal failure after only eight weeks of
observation. Renal or glomerular hypertrophy was also aug-
mented by a high salt diet in both the control and ADR rats.
Among the many factors associated with the development of renal
destruction, either renal or glomerular hypertrophy might be a
possible factor leading to the aggravative effects of the high salt
diet in ADR-nephropathy. The glomerular sclerosisng process has
been reported to be accelerated in the remnant kidney with a
variety of experimental glomerular diseases including ADR-
nephropathy [32—34]. Lax et al [16} reported that salt intake had
no effect on glomerular hemodynamics but was related to hyper-
trophic response in the remnant kidney. Salt intake has also been
reported to influence compensatory renal growth [11—16]. Dietary
salt restriction inhibited the hypertrophic responses to ablation
and reduced glomerular injury in uninephrectomized spontane-
ously hypertensive rats [14]. The effect of salt consumption on
renal size and composition has been studied in Dahl rats, in which
renal growth due to hyperplasia accompanies the ingestion of a
high salt diet in both salt sensitive and resistant rats. NHE has also
been reported to be up-regulated by a high salt intake in Dahi salt
sensitive rats [13]. These findings suggested that the aggravative
effects of a high salt diet on kidney tissue may be mainly related to
renal hypertrophy through the up-regulated NHE activity.
However, NHE mRNA was not up-regulated in the control rats
fed an 8% NaCI diet regardless of hypertrophic effect of a high
salt diet on kidney or glomeruli. The up-regulation of NHE
mRNA was also not observed in ADR rats at week 2, when renal
or glomerular hypertrophy was evident without the significant
histological destructions. Recent reports have shown that the
inhibition of Na/H exchanger activity failed to block cell
hypertrophy [35—37]. Mackovic-Basic et al [38] have found, using
mutant cells with decreased NHE, that the stimulation of NHE is
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Table 1. Laboratory findings
ADR-
Week
Control-l%(N 6) Control-8%(N = 6) ADR-1%(N = 8) ADR-8%(N = 8) ADR-8%Fu(N = 8) 8%Am(N = 8)
Body wtg
Kidney wt g
2
8
2
8
415 16
433 12
1.02 0.01
1,18 0.08
402 21
413 24
1.32 0.02°
1,49 0.07°
361 12°
372 iia
1.82 0.14°
1.90 0.29°
351 21°
346 31°
2.43 0.41°"
2.01 0.43°
363 27°
368 18°
2.22 042a,b
2.07 0.26°
366 27°
351 23°
1.86 0.22°
1.86 0.23a
BP mm Hg 2
8
128 4
129 6
131 4
131 5
136 5°141 5 138 5141 4° 140 4°143 7° 141 6°139 a
UP mg/day 2
8
8 3
12 3
10 4
14 6
325 66°
288 57°
386 85°
294 75°
329 96°
304 84°
385 87°
288 70°
Ccr mI/mm 2
8
0.26 0.04
0.29 0.05
0.28 0.07
0.27 0.06
0.27 0.04
0.29 0.05
0.24 0.05
0.10 0.08°
0.26 0.08
0.12 0.08°
0,30 0.06
0.28 0.06
SNa mEqiliter 2
8
142 1
141 2
148 2
149 3
142 2
141 2
147 2°
148 3°
142 3
143 1
142 2
142 2
Abbreviations are: wt, weight; BP, blood pressure; UP, urinary protein; C, creatinine clearance; SNa, serum sodium concentration. Each value
represents the mean SD.
P < 0.01 compared with the control-1% groupbP < 0.01 compared with the ADR-1% group
Fig. 5. Glomendar diameter (mean SEM) (A)
at week 2 and (B) at week 8. *P < 0.05
compared to the control-1% group. P < 0.01
compared to control-8% or ADR-1% groups.
Fig. 6. Degree of glomerulosclerosis (mean
SEM) (A) at week 2 and (B) at week 8. *D < 0.01
compared to the control-1%, control-8%, ADR-
1% or ADR-8%Am groups.
not essential for the induction of hypertrophy in renal cells. In ADR rats fed a high salt diet at week 8 was related to therenal
addition, in uninephrectomized mice, amiloride failed to inhibit lesions without the contribution to renal hypertrophic effect, the
compensatory renal growth [39]. In the present study, the hyper- ameliorative effects of amiloride on renal tissue suggest that NHE
trophic effect of a high salt diet was unlikely to be mediated may be necessary for developing process of renal lesions in the
through NHE activation. ADR rats fed a high salt diet. As described above, the NHE
Although it is unclear whether the up-regulated NHE in the activation may be a common cellular response of growth factors
A NHE mRNA (2 weeks) B NHE mANA (8 weeks)
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Fig. 7. Degree of interstitial fibrosis (mean
rEM) (A) at week 2 and (B) week & *p < 0.01
compared to the control-1%, control-8%, ADR-
1% or ADR-8%Am groups.
Fig. 8. Northern blotting for NHE-1 mRNA (A) at week 2 and (B) at week & Ten microgram of poiy (A) mRNA from the renal cortex in each group
were loaded into each lane. Poly (A) mRNA was hybridized with rat NHE-1 eDNA and GAPDH eDNA. The same results were obtained in three
different experiments. The scanning data of the RNA transfer blot are shown.
which are involved in the proliferative changes and matrix accu-
mulation in the kidney. Further, amiloride reduces sodium reten-
tion in the rats fed a high salt diet by inhibiting the NHE activity.
A high salt diet may cause extracellular volume expansion which
leads to either systemic or glomerular hypertension. The effect of
salt loading on glomerular hemodynamics might exacerbate the
renal lesions in the ADR rats fed a high salt diet. However, no
increase in body weight or blood pressure was observed in the rats
fed a high salt diet. Furosemide could not attenuate the renal
lesions, although it is a potent agent to inhibit sodium reabsorp-
tion. Thus, the inhibition of sodium retention does not seem to be
a main factor for ameliorative effects of amiloride. On the other
hand, amiloride is a relatively non-specific inhibitor that has many
effects other than inhibition of the NHE. It is known to inhibit the
Na/K-ATPase and to inhibit protein synthesis. The possibility
that the effect of amiloride on renal lesions in ADR rats fed a high
salt diet might thus be attributed to other effects than the
inhibition of NHE exchanger remains to be clarified.
In summary, the renal NHE mRNA expression was up-regu-
lated in the ADR rats in parallel with the degree of renal
destruction. Amiloride prevented renal lesions in both the ADR
rats and the ADR rats fed a high salt diet. A high salt diet thus had
a hypertrophic and destructive effect on the kidney and glomeruli
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in the ADR rats, The hypertrophic effects did not seem to be
mediated through NHE activation by a high salt diet.
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